Device Firms Cheer ICD-10 Debut, While Providers Brace For Chaos
This article was originally published in The Gray Sheet
The ICD-10 health care coding set has finally launched after much debate and delay. Medical device manufacturers cheer the transition as a means to better capture new technology in the insurance system, but health care providers are bracing for technical headaches and the risk of claims not being paid.
You may also be interested in...
AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.